Integration of Gut Microbiota, Serum Metabolomic, and Network Pharmacology to Reveal the Anti Insomnia Mechanism of Mongolian Medicine Sugemule-4 Decoction on Insomnia Model Rats
Drug Design, Development and Therapy · 2024
DOI: 10.2147/dddt.s455600 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Lina Du und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Mongolian Medical, Inner Mongolia Medical University, Hohhot, Inner Mongolia, People's Republic of China. Hauptthemen laut MEDLINE: Sleep Initiation and Maintenance Disorders, Network Pharmacology, Gastrointestinal Microbiome, Disease Models, Animal. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Schlaf
Abstract (Originalsprache)
Objective
To explored the potential molecular mechanism of Sugemule-4 decoction (MMS-4D) in treating insomnia.
Methods
DL-4-chlorophenylalanine (PCPA) + chronic unpredictable mild stress stimulation (CUMS) was used to induce an insomnia model in rats. After the model was successfully established, MMS-4D was intervened at low, medium, and high doses for 7 days. The open-field test (OFT) was used to preliminarily evaluate the efficacy. The potential mechanism of MMS-4D in treating insomnia was investigated using gut microbiota, serum metabolomics, and network pharmacology (NP). Experimental validation of the main components of the key pathways was carried out using ELISA and Western blot.
Results
The weights of the insomnia-model rats were significantly raised (p ≤ 0.05), the total exercise distance in the OFT increased (p ≤ 0.05), the rest time shortened, and the number of standing times increased (p ≤ 0.05), after treatment with MMS-4D. Moreover, there was a substantial recovery in the 5-HT, DA, GABA, and Glu levels in the hypothalamus tissue and the 5-HT and GABA levels in the colon tissue of rats. The expression of DAT and DRD1 proteins in the hippocampus of insomnia rats reduced after drug treatment. MMS-4D may treat insomnia by regulating different crucial pathways including 5-HT -, DA -, GABA -, and Glu-mediated neuroactive light receiver interaction, cAMP signaling pathway, serotonergic, glutamatergic, dopaminergic, and GABAergic synapses.
Conclusion
This study revealed that MMS-4D can improve the general state and behavioral changes of insomnia model rats. Its mechanism may be related to the reversal of abnormal pathways mediated by 5-HT, DA, GABA, and Glu, such as Serotonergic synapse, Dopaminergic synapse, Glutamatergic synapse, and GABAergic synapse.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Mongolian Medical, Inner Mongolia Medical University, Hohhot, Inner Mongolia, People's Republic of China.
- Innovative Mongolian Medical Engineering Research Center, Inner Mongolia International Mongolian Hospital, Hohhot, Inner Mongolia, People's Republic of China.
Zitieren
APA
Du, L., Yang, D., Wu, L., Mei, L., Wu, S., Ba, Y., Bao, Y., Su, R., & Song, L. (2024). Integration of Gut Microbiota, Serum Metabolomic, and Network Pharmacology to Reveal the Anti Insomnia Mechanism of Mongolian Medicine Sugemule-4 Decoction on Insomnia Model Rats. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s455600
Vancouver
Du L, Yang D, Wu L, Mei L, Wu S, Ba Y, et al. Integration of Gut Microbiota, Serum Metabolomic, and Network Pharmacology to Reveal the Anti Insomnia Mechanism of Mongolian Medicine Sugemule-4 Decoction on Insomnia Model Rats. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s455600
BibTeX
@article{Du2024,
author = {Du, Lina and Yang, Dezhi and Wu, Lan and Mei, Li and Wu, Sarula and Ba, Yasula and Bao, Yongchang and Su, Rigugaqiqige and Song, Lin},
title = {Integration of Gut Microbiota, Serum Metabolomic, and Network Pharmacology to Reveal the Anti Insomnia Mechanism of Mongolian Medicine Sugemule-4 Decoction on Insomnia Model Rats},
journal = {Drug Design, Development and Therapy},
year = {2024},
doi = {10.2147/dddt.s455600}
}
EUVIMED